InvestorsHub Logo

ClosetInvestor

04/12/22 10:41 AM

#207097 RE: moneycrew #207092

The market disagrees. Animal studies mean little at this point and investors are well aware of leronlimab’s use in monotherapy. What we don’t have is a phase 3 study with statically significant results showing efficacy in mono therapy patients. Until we do, animal studies and 5 patient cohorts mean little.

Rubraquercus

04/12/22 11:13 AM

#207103 RE: moneycrew #207092

2 for one sale and you get a free waffle cone with every order!

Grip it and Sip It

04/12/22 12:10 PM

#207111 RE: moneycrew #207092

Confirming they're done, running out of shares, growing concern to continue, FDA halt! Haha

Yeah- totally debunked! It will be $.22 soon

dloggold

04/12/22 12:20 PM

#207112 RE: moneycrew #207092

they followed 5 patients?
lol